Reviews

The Optimal Dose Fractionation Schema for Malignant Extradural Spinal Cord Compression

Publish date: July 2, 2011

 

Copyright © 2011 Published by Elsevier Inc.

Pages

Recommended Reading

Denosumab Not Cost Effective in Solid Tumor Bone Metastases
MDedge Hematology and Oncology
Novel Anticoagulant Prevents VTEs During Chemotherapy
MDedge Hematology and Oncology
Childhood Cancer Survivors at Higher Risk for Melanoma Risk
MDedge Hematology and Oncology
FDA Tightens ESA Dosing Recommendations for CKD Anemia
MDedge Hematology and Oncology
Hepcidin Levels Predict ESA and IV Iron Responses
MDedge Hematology and Oncology
Video Report: Patient Care Themes and Trends at ASCO 2011
MDedge Hematology and Oncology
Challenges of ensuring adherence to oral therapy in patients with solid malignancies
MDedge Hematology and Oncology
A case of lung cancer and hypercoagulability, complicated by suspected heparin-induced thrombocytopenia
MDedge Hematology and Oncology
Pharmaceutical patient assistance programs in the outpatient pharmacy of a large tertiary cancer center
MDedge Hematology and Oncology
IV iron sucrose for cancer and/or chemotherapy-induced anemia in patients treated with erythropoiesis-stimulating agents
MDedge Hematology and Oncology

Related Articles